Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

OB GYN new masthead 1

June 1, 2015

View Archives Issues

  • Isotretinoin and Contraception: Should iPLEDGE Be Changed?

    In this study of female dermatologic patients, knowledge of the typical effectiveness of contraceptive methods increased after viewing a simple information sheet. Given the teratogenicity of isotretinoin, expanding the use of highly effective contraceptive methods among women of child-bearing potential using this medication is essential.

  • Are We Ready to Give Up the Pap Smear?

    A review of the ATHENA trial, which evaluated the prevalence of hrHPV in a large cohort of women and evaluated the most sensitive screening strategy.

  • Mammograms: The Cost of Overdiagnosis

    In the United States, the costs associated with the management of false-positive mammograms and breast cancer overdiagnosis is estimated to be $4 billion each year.

  • Macrosomia

    Previous Alerts have touched on the relationship between big babies and big problems, such as birth injury, infant/childhood obesity, and diabetes. This special feature is designed to provide a more comprehensive look at the causes, risks, prediction, management, and prevention of macrosomia.